Overview
We are seeking volunteers to participate in a migraine clinical research study. Your participation in clinical research is critical to helping researchers discover the effectiveness of a migraine treatment. By joining this research study, you are not just a participant, you are a vital contributor to future potential investigational treatments.
About this Study
STUDY TO ASSESS EFFICACY AND SAFETY OF RIMEGEPANT FOR THE TREATMENT OF MIGRAINE (WITH OR WITHOUT AURA) IN CHILDREN AND ADOLESCENTS ≥ 6 TO < 18 YEARS OF AGE
We are looking for children between the age of 6-18 years old for a compensated pediatric migraine study.
This clinical trial is evaluating a pediatric migraine research study. The goal is to help advance medical knowledge about migraines and contribute to the body of medical science. You can join a no-cost research study and play a role in helping advance medical research.
Who Can Join
- Be between 6 and 18 years old
- Have a history of migraines for at least 6 months prior to screening
- Have a history of 1 to 8 moderate or severe attacks per month
- Weigh at least 33 lbs.
- Have a history of Migraines for at least 6 months
- 1-8 Migraines per month in the last 2 months which last more than 3 hours if untreated
Exclusions:
- Combination of cluster headaches
- Migraines with Aura or Hemiplegic Migraines
- History of moderate or severe head trauma or other neurological disorder (including seizure disorder)
- Use of a CGRP antagonist, such as erenumab or fremanezumab, is prohibited
*Other conditions apply
Not sure if your child qualifies? A member of our study team will review your child’s medical history and medications to determine if this study may be a good fit.
What to Expect
Study Duration:
Up to 19 weeks
Study Visits:
Up to 4 site visits
Compensation:
Participants may receive compensation up to $338
*$47 per visits and $150 for eDiary